High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents

Abstract

Lactate dehydrogenase is a readily available and inexpensive variable, which has a major impact on the survival of myeloma patients even when they belong to a low or intermediate ISS subgroup and even when they receive novel agent-based therapies.